Provider Comparisons9 min read

Novi vs EnhanceMD: Low All-In GLP-1 Pricing vs Lab-Monitored Flat-Rate Care in 2026

Novi is the better fit if you want low all-in GLP-1 pricing, free 2-day shipping, coaching, and unlimited clinician messaging. EnhanceMD is stronger if you want low first-month entry pricing, no dose escalation fees, metabolic labs every 6 months, and specific semaglutide or tirzepatide checkout paths.

Short Answer: Novi for Low Bundled Pricing, EnhanceMD for Labs and Flat-Rate Dosing

Choose Novi if you want low all-in compounded GLP-1 pricing with the support pieces bundled in. PeptidePub rates Novi 4.3 out of 5 and lists compounded semaglutide from $174/month and compounded tirzepatide from $283/month. Consultation, coaching, unlimited clinician messaging, dose adjustments as needed, and free 2-day shipping are included in the local review.

Choose EnhanceMD if you want low first-month entry pricing, flat-rate dosing, and metabolic labs. PeptidePub rates EnhanceMD 4.3 out of 5 and lists GLP-1 Core semaglutide at $49 first month, then $212/month; GLP-1 Advanced tirzepatide at $99 first month, then $280/month; and GLP-1 Elite semaglutide plus tirzepatide combo at $189 first month, then $322/month. Labs are included every 6 months.

The clean buyer answer: Novi is the better fit for budget-conscious buyers who want coaching, messaging, and fast shipping bundled into a lower ongoing semaglutide price. EnhanceMD is stronger for buyers who want lab-monitored, same-price-at-every-dose care with specific semaglutide and tirzepatide checkout paths.

Use /go/novi for Novi. Use /go/enhancedmd for EnhanceMD overall, /go/enhancedmd-semaglutide for semaglutide intent, and /go/enhancedmd-tirzepatide for tirzepatide intent.

Both reviews discuss compounded semaglutide and compounded tirzepatide. These are not FDA-approved finished drugs, and they are not generic Ozempic, Wegovy, Mounjaro, or Zepbound.

Novi vs EnhanceMD Comparison Snapshot

Price: Novi lists compounded semaglutide from $174/month and compounded tirzepatide from $283/month in the local review. EnhanceMD lists semaglutide at $49 first month, then $212/month, and tirzepatide at $99 first month, then $280/month. EnhanceMD also lists the Elite semaglutide plus tirzepatide combo at $189 first month, then $322/month, microdosing tirzepatide at $169/month, and NAD+ injections at $169/month.

Support: Novi includes a 3-minute online quiz, licensed clinician review, unlimited clinician support and messaging, coaching, dose adjustments as needed, and free 2-day shipping. EnhanceMD includes a medical consultation with a licensed provider, ongoing provider support, dose adjustments as needed, lab testing every 6 months, a money-back guarantee if found ineligible, and the same price at every dose.

Medication format: both local reviews describe compounded injections only. Novi says there are no oral alternatives. EnhanceMD says there are no oral, lozenge, or drop formats.

Best fit: Novi if you want a lower all-in local semaglutide baseline and a more support-forward bundle. EnhanceMD if you want lower first-month pricing, lab monitoring, and predictable dosing costs.

For broader comparison shopping, use /providers and /prices. For provider-level detail, use /reviews/novi and /reviews/enhancedmd.

Price and Year-One Math

Novi is cheaper on local semaglutide math after month one. At $174/month, Novi semaglutide is $2,088/year. At $283/month, Novi tirzepatide is $3,396/year.

EnhanceMD starts lower but rises after the first month. Semaglutide is $49 first month plus 11 months at $212, or $2,381 in year one. Tirzepatide is $99 first month plus 11 months at $280, or $3,179 in year one. That makes EnhanceMD slightly cheaper than Novi for local tirzepatide baseline pricing, but more expensive for local semaglutide baseline pricing.

Novi has lower external promotional signals, but treat them as checkout signals, not guarantees. Finance Yahoo and Explore Treatments results accessed 2026-07-09 said Novi lists compounded semaglutide from $133/month and compounded tirzepatide from $166/month. If those prices applied all year, semaglutide would be $1,596/year and tirzepatide would be $1,992/year. Readers should verify live checkout price, promo length, refill price, and whether any 3-month minimum applies.

EnhanceMD pricing is also term-dependent. Vaccine Alliance reported Core semaglutide at $212/month on 12 months, $224 on 6 months, $237 on 3 months, or $249 month-to-month. Advanced tirzepatide was $280, $296, $313, or $329/month by the same term lengths. Elite was $322, $341, $360, or $379/month.

Bariatric Journal reported $49 first month then $249/month month-to-month for semaglutide, reducing to around $212/month with a year-long payment period. Bottom line: checkout term length controls the real bill.

Support, Coaching, Labs, and Shipping

Novi wins if you care most about bundled support. The local review says consultation, shipping, and coaching are included in the monthly cost. It also lists unlimited clinician support and messaging, dose adjustments as needed, quick onboarding, and free 2-day shipping.

That bundle matters because a low medication price can become less useful if coaching, shipping, clinician access, or refill help costs extra. Novi is positioned for buyers who want a streamlined online path: 3-minute quiz, licensed clinician review, prescription if appropriate, and medication shipped directly.

EnhanceMD wins if you want lab-monitored follow-up. The local review lists metabolic lab testing every 6 months, ongoing provider support, dose adjustments as needed, and a money-back guarantee if found ineligible. Labs can help track metabolic health beyond scale weight, but they do not guarantee better outcomes for every patient.

EnhanceMD also has a clearer no-dose-escalation-fee pitch. The local review says the price stays the same at every dose, which is useful because some GLP-1 programs get more expensive as dose rises.

Do not overread the difference. Novi looks stronger for coaching, messaging, and shipping. EnhanceMD looks stronger for labs and flat-rate dose escalation. Neither should be treated as automatically having better pharmacy quality unless the provider discloses pharmacy-specific evidence that the buyer can verify.

Medication Options and Evidence Context

Both provider reviews discuss compounded semaglutide and compounded tirzepatide. For molecule background, use /peptides/semaglutide and /peptides/tirzepatide. The treatment context is weight-loss GLP-1 care, but the evidence needs to be framed carefully.

In the STEP 1 NEJM semaglutide trial, adults with overweight or obesity had mean body-weight change of -14.9% with semaglutide 2.4 mg versus -2.4% with placebo at week 68. In SURMOUNT-1, tirzepatide groups had average weight reductions of 16.0%, 21.4%, and 22.5% for 5 mg, 10 mg, and 15 mg at 72 weeks, compared with 2.4% placebo in Lilly's summary.

Those numbers are active-ingredient and brand-drug evidence context. They do not prove that compounded semaglutide or compounded tirzepatide has identical trial evidence, FDA approval, manufacturing controls, or outcomes.

EnhanceMD also lists a GLP-1 Elite semaglutide plus tirzepatide combo plan. Treat that as a program feature, not proof of superior outcomes. This comparison should not recommend combination therapy, microdosing, switching, or stacking.

Safety, Compounding, and Buyer Verification

FDA's 2026-04-01 GLP-1 compounding clarification says compounded drugs must meet section 503A or 503B conditions to qualify for exemptions. Under 503A, compounded drugs are made for an individual patient after receipt of a valid prescription, and compounders cannot regularly or in inordinate amounts compound products that are essentially copies of commercially available drugs.

For 503B outsourcing facilities, FDA says bulk drug substances are restricted unless the substance appears on the 503B bulks list or the drug is on FDA's shortage list at the time of compounding, distribution, and dispensing.

FDA also says semaglutide and tirzepatide do not currently appear on the 503B bulks list or the FDA drug shortage list in that 2026-04-01 clarification. FDA says compounded drugs are not FDA-approved finished drugs and are not reviewed by FDA for safety, effectiveness, and quality before marketing.

Before paying either provider, verify the exact medication, compounded versus brand status, pharmacy name, prescriber credentials, state eligibility, live monthly price, payment term, refill price, dose escalation fees, labs, shipping, supplies, refund if not prescribed, cancellation deadline, and side-effect support.

Who Should Choose Novi

Choose Novi if you want the lower local semaglutide baseline and a support bundle. The local review lists semaglutide from $174/month and tirzepatide from $283/month, with consultation, coaching, unlimited clinician messaging, dose adjustments, and free 2-day shipping included.

Novi is a strong fit for budget-conscious buyers who want a fast 3-minute quiz, licensed clinician review, and no long-term contract in the local review. It is less ideal if you want brand-name Ozempic, Wegovy, Mounjaro, or Zepbound, oral medication formats, built-in metabolic labs, or zero ambiguity around possible 3-month commitment language.

The commitment caveat matters. The local review says no long-term contracts and cancel anytime, but also flags that terms of service may reference a 3-month minimum. Explore Treatments reported a similar month-to-month FAQ versus 3-month terms issue. Verify it before checkout.

Use /go/novi if your top priority is low bundled access plus coaching and messaging. PeptidePub currently uses a direct non-affiliate Novi link because prior Eden plus Novi Katalys offers were dead as of 2026-07-07.

Who Should Choose EnhanceMD

Choose EnhanceMD if low first-month entry pricing and predictable dosing costs matter more than the lowest ongoing semaglutide headline. The local review lists semaglutide at $49 first month, then $212/month, and tirzepatide at $99 first month, then $280/month.

EnhanceMD is also the better fit if you want no dose escalation fees, same price at every dose, metabolic lab testing every 6 months, a money-back guarantee if found ineligible, and specific checkout paths for semaglutide or tirzepatide.

It is less ideal if you want the lowest local semaglutide monthly price after month one, daily oral formats, lozenges, drops, brand-name medication paths, or dedicated coaching as a structured program. The local review is compounded only and injections only.

Use /go/enhancedmd for general EnhanceMD intent. Use /go/enhancedmd-semaglutide if the reader already knows they are comparing semaglutide programs, and /go/enhancedmd-tirzepatide if they are comparing tirzepatide programs.

FAQ

Is Novi cheaper than EnhanceMD? For local semaglutide baseline pricing, yes after month one. Novi is $174/month. EnhanceMD is $49 first month, then $212/month. For tirzepatide, EnhanceMD is slightly cheaper after month one at $280/month versus Novi at $283/month.

Does Novi include labs? The local Novi review lists consultation, free 2-day shipping, coaching, unlimited clinician messaging, and dose adjustments, but not metabolic lab testing. EnhanceMD lists metabolic lab testing every 6 months.

Which has more predictable pricing? EnhanceMD has the clearer flat-rate dosing story because the local review says the price stays the same at every dose. Novi has attractive bundled pricing, but buyers should verify live price, promo terms, refill terms, and any 3-month minimum.

Are Novi and EnhanceMD selling FDA-approved generics? No. Both local reviews discuss compounded semaglutide and tirzepatide. Compounded products are not FDA-approved finished drugs or FDA-approved generics.

Bottom Line

Novi wins for low bundled GLP-1 access. The local review lists $174/month semaglutide, $283/month tirzepatide, consultation included, coaching included, unlimited clinician messaging, dose adjustments as needed, and free 2-day shipping. It is the cleaner pick for price-sensitive buyers who want support without lab monitoring built into the package.

EnhanceMD wins for lab-monitored flat-rate care. The local review lists $49 first-month semaglutide then $212/month, $99 first-month tirzepatide then $280/month, no dose escalation fees, labs every 6 months, ongoing provider support, and a money-back guarantee if found ineligible.

If the top concern is lowest local ongoing semaglutide price plus coaching, use /go/novi. If the top concern is lab monitoring and same-price-at-every-dose predictability, use /go/enhancedmd. For medication-specific intent, use /go/enhancedmd-semaglutide or /go/enhancedmd-tirzepatide.

Before checkout, verify live price, commitment term, product identity, pharmacy, refill terms, cancellation deadline, state eligibility, and medical fit. That final check matters more than any comparison-table winner.

Get peptide price-drop alerts

Set a target price and we'll email you when a trusted, third-party-tested vendor drops below it. No spam, unsubscribe anytime.